Hidalgo Medina Manuel 4
Research Summary
AI-generated summary
Guardant Health Director Hidalgo Medina Manuel Receives 232 RSU Shares
What Happened Hidalgo Medina Manuel (Director) had a restricted-stock derivative converted into 232 common shares on February 17, 2026. The Form 4 reports an acquisition of 232 shares at $0.00 and a corresponding disposal of a derivative interest (232 units) at $0.00 — indicating RSU vesting/conversion rather than a cash purchase or open-market trade. No cash was paid; the reported dollar value of the transaction is $0.
Key Details
- Transaction date: 2026-02-17; filing date: 2026-02-18 (filed timely).
- Reported amounts/prices: 232 shares acquired @ $0.00; 232 derivative units disposed @ $0.00.
- Shares owned after transaction: Not specified in the filing.
- Footnotes: F1 — The RSU award granted July 17, 2024 vests over four years (25% at one year, then monthly vesting over the next three years). F2 — Not applicable for RSUs.
- Filing timeliness: Reported the next day, so no late-filing indication.
Context This was a routine vesting/conversion of restricted stock units into common shares (derivative converted to underlying shares), not an open-market buy or sale. Such vesting is compensation-related and should be viewed differently than a director buying or selling stock; it does not by itself signal a change in insider sentiment.